First Interstate Bank’s Supernus Pharmaceuticals SUPN Stock Holding History

First Interstate Bank’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-469	Closed	-$16K	–	666
2019 Q2	$16K	Buy	+469	New	+$16.1K	﹤0.01%	499
2018 Q2	–	Sell	-400	Closed	-$18K	–	699
2018 Q1	$18K	Hold	400	–	–	﹤0.01%	505
2017 Q4	$16K	Hold	400	–	–	﹤0.01%	528
2017 Q3	$16K	Sell	400 -89	-18%	-$3.85K	﹤0.01%	500
2017 Q2	$21K	Buy	489 +107	+28%	+$3.81K	﹤0.01%	438
2017 Q1	$12K	Hold	382	–	–	﹤0.01%	519
2016 Q4	$10K	Buy	+382	New	+$8.54K	﹤0.01%	561

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

ACM

Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return

First Interstate Bank's SUPN Position: Q3 2019 in Review

First Interstate Bank sold out of Supernus Pharmaceuticals (SUPN) in Q3 2019, closing a stake of 469 shares — an estimated $16K sold.

First Interstate Bank first reported a position in SUPN in Q4 2016 and held it in 7 quarters. The position peaked at $21K in Q2 2017. 243 funds tracked by Wall St. Rank hold SUPN as of Q3 2019.

First Interstate Bank reported no remaining Supernus Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
First Interstate Bank sold 469 Supernus Pharmaceuticals shares in Q3 2019, an estimated $16K.
First Interstate Bank first reported a position in Supernus Pharmaceuticals in Q4 2016 and held it in 7 quarters.
First Interstate Bank's Supernus Pharmaceuticals position peaked at $21K in Q2 2017.
243 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2019.

Based on First Interstate Bank's 13F filing for Q3 2019, filed 30 Oct 2019.